200 related articles for article (PubMed ID: 12448549)
1. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
Jones OA; Voulvoulis N; Lester JN
Water Res; 2002 Dec; 36(20):5013-22. PubMed ID: 12448549
[TBL] [Abstract][Full Text] [Related]
2. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use.
Stuer-Lauridsen F; Birkved M; Hansen LP; Lützhøft HC; Halling-Sørensen B
Chemosphere; 2000 Apr; 40(7):783-93. PubMed ID: 10705557
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
Liebig M; Moltmann JF; Knacker T
Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
[TBL] [Abstract][Full Text] [Related]
4. Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.
Straub JO; Oldenkamp R; Pfister T; Häner A
Environ Toxicol Chem; 2019 Oct; 38(10):2259-2278. PubMed ID: 31225916
[TBL] [Abstract][Full Text] [Related]
5. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
Ferrari B; Mons R; Vollat B; Fraysse B; Paxéus N; Lo Giudice R; Pollio A; Garric J
Environ Toxicol Chem; 2004 May; 23(5):1344-54. PubMed ID: 15180389
[TBL] [Abstract][Full Text] [Related]
6. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER.
Schowanek D; Webb S
Toxicol Lett; 2002 May; 131(1-2):39-50. PubMed ID: 11988357
[TBL] [Abstract][Full Text] [Related]
7. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
[TBL] [Abstract][Full Text] [Related]
8. A framework for prioritizing fragrance materials for aquatic risk assessment.
Salvito DT; Senna RJ; Federle TW
Environ Toxicol Chem; 2002 Jun; 21(6):1301-8. PubMed ID: 12069318
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.
Letsinger S; Kay P
Environ Sci Pollut Res Int; 2019 Feb; 26(4):3479-3491. PubMed ID: 30515684
[TBL] [Abstract][Full Text] [Related]
10. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL; Binks SP; Olson MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
[TBL] [Abstract][Full Text] [Related]
11. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
Boxall AB; Keller VD; Straub JO; Monteiro SC; Fussell R; Williams RJ
Environ Int; 2014 Dec; 73():176-85. PubMed ID: 25127044
[TBL] [Abstract][Full Text] [Related]
12. Theoretical environmental risk assessment of ten used pharmaceuticals in Belo Horizonte, Brazil.
Neves AC; Mol MPG
Environ Monit Assess; 2019 Apr; 191(5):275. PubMed ID: 30976940
[TBL] [Abstract][Full Text] [Related]
13. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
Donnachie RL; Johnson AC; Sumpter JP
Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
[TBL] [Abstract][Full Text] [Related]
14. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
[TBL] [Abstract][Full Text] [Related]
15. Human pharmaceuticals in US surface waters: a human health risk assessment.
Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
[TBL] [Abstract][Full Text] [Related]
16. Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose?
Burns EE; Thomas-Oates J; Kolpin DW; Furlong ET; Boxall ABA
Environ Toxicol Chem; 2017 Oct; 36(10):2823-2832. PubMed ID: 28477358
[TBL] [Abstract][Full Text] [Related]
17. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.
Ortiz de García S; Pinto Pinto G; García Encina P; Irusta Mata R
Sci Total Environ; 2013 Feb; 444():451-65. PubMed ID: 23287535
[TBL] [Abstract][Full Text] [Related]
18. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy.
Castiglioni S; Fanelli R; Calamari D; Bagnati R; Zuccato E
Regul Toxicol Pharmacol; 2004 Feb; 39(1):25-32. PubMed ID: 14746777
[TBL] [Abstract][Full Text] [Related]
19. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
[TBL] [Abstract][Full Text] [Related]
20. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP; Garric J
Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
